Key Considerations of Gene Therapy Development: A Caregiver's Story

from ASGCT Podcast Network · host American Society of Gene & Cell Therapy

Emily Walsh Martin, PhD, spoke with Amber Freed, founder and CEO of SLC6A1 Connect, a patient organization focused on accelerating the development of therapies for SLC6A1 patients like her son Maxwell.Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

Episode metadata supplied by the publisher feed · Published Apr 6, 2026

Embed this episode

Attribution link and audio player

Ready to play

Key Considerations of Gene Therapy Development: A Caregiver's Story

0:00 35:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of ASGCT Podcast Network?

This episode is 35 minutes long.

When was this ASGCT Podcast Network episode published?

This episode was published on April 6, 2026.

Can I download this ASGCT Podcast Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!